Validation of SOFA-2 for Mortality and Sepsis-3 Prevalence in Turkey
Recruiting
Observational Study
Sepsis
Septic Shock
Critical Illness
Organ Dysfunction
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 2,500 (estimated)
- Sponsor
- Marmara University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this observational study is to validate the effectiveness of the new SOFA-2 score in predicting mortality and to determine the current frequency of sepsis in adult patients admitted to Intensive Care Units (ICUs) in Turkey. The main questions it aims to answer are:
* Does the SOFA-2 score accurately predict 30-day mortality in ICU patients?
* What is the prevalence of Sepsis-3 and sep…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patients aged 18 years or older.
* Admitted to the Intensive Care Unit (ICU) during the specified study recruitment window.
* For the Validation Cohort: Patients staying in the ICU for at least 24 hours.
* For the Point Prevalence Cohort: Patients present in the ICU at 08:00 A…
Contacts